I now have rich, detailed content. Let me compile the full answer on principles in management of preterm labour.
Principles in Management of Preterm Labour
The management of preterm labour rests on a small number of core principles, each targeting a specific and measurable goal. These principles apply from the moment preterm labour is confirmed through to delivery planning.
Principle 1: Confirm the Diagnosis Before Intervening
Before any treatment is started, active preterm labour must be confirmed. Over-treatment of women who are not in true preterm labour is a real clinical problem.
- Diagnosis requires: Regular uterine contractions plus documented cervical change (≥2 cm dilation, ≥80% effacement, or progression on serial exams)
- Contractions without cervical change do not warrant tocolytic therapy; initiating tocolysis for unconfirmed preterm labour is actively discouraged
- Assess with: CTG, digital cervical exam (after excluding PROM), and fetal fibronectin (fFN) swab at 22-35 weeks before digital exam
- Negative fFN = delivery within 7-10 days extremely unlikely (very high NPV) - can safely avoid treatment
- Exclude PROM with sterile speculum exam, nitrazine, and ferning before digital exam
"Initiation of tocolytic therapy for potential but unconfirmed preterm labor is discouraged." - Mulholland & Greenfield's Surgery 7e
Principle 2: Identify and Treat Reversible Causes
Uterine, cervical, and urinary tract infections account for 20-40% of preterm labour cases. Before reaching for tocolytics, basic corrective steps must be taken:
- Supplemental oxygen - uterine hypoxia can itself drive contractions
- IV crystalloid hydration (500 mL) - dehydration is a common precipitant; can reduce contraction frequency
- Left lateral decubitus position - improves uterine and placental perfusion
- Urinalysis + culture - treat UTI/pyelonephritis promptly
- Rule out chorioamnionitis: fever, uterine tenderness, maternal/fetal tachycardia, leukocytosis, purulent discharge
- Screen for GBS, Chlamydia, GC, bacterial vaginosis
- If contractions persist after these measures and cervical change is confirmed, proceed to pharmacologic therapy
"Because uterine, cervical, or urinary tract infections account for 20% to 40% of cases of preterm labor, search for a specific cause and treat infections appropriately." - Roberts & Hedges' Clinical Procedures in Emergency Medicine
Principle 3: Assess Contraindications to Labour Arrest
Stopping preterm labour is NOT always appropriate. Before any tocolysis, confirm there is no indication for prompt delivery.
Absolute contraindications to tocolysis:
| Maternal | Fetal |
|---|
| Chorioamnionitis | Gestational age >37 weeks |
| Severe preeclampsia / eclampsia | Fetal compromise requiring delivery |
| Abruptio placentae / significant haemorrhage | Lethal fetal anomaly |
| Placenta praevia with haemorrhage | Fetal demise |
| Maternal haemodynamic instability | Chorioamnionitis |
| Significant maternal cardiac disease | |
Relative contraindications: vaginal bleeding, poorly controlled hypertension, maternal diabetes with complications.
- Vaginal spotting from cervical effacement is acceptable, but anything beyond light spotting must prompt exclusion of abruption and praevia
- In extreme prematurity with borderline haemorrhage, short-term tocolysis to gain corticosteroid benefit may occasionally be considered with caution
Principle 4: Delay Delivery by 48-72 Hours (the actual goal of tocolysis)
Tocolytics do NOT prevent preterm birth. Their only proven, clinically meaningful goal is to buy 48-72 hours to:
- Administer antenatal corticosteroids (which need ~24 hours to work)
- Transfer the mother to a tertiary facility with neonatal ICU capability
- Administer MgSO4 for neuroprotection
"Although tocolytic agents delay delivery in approximately 80% of women, they neither prevent premature births nor improve adverse fetal outcomes such as respiratory distress syndrome." - Goodman & Gilman's Pharmacological Basis of Therapeutics
"The goal of delaying delivery is to enable administration of antenatal corticosteroids for lung maturation and magnesium sulfate for neuroprotection, as well as to permit maternal transport to a tertiary facility." - Roberts & Hedges' Clinical Procedures in Emergency Medicine
Principle 5: Administer Antenatal Corticosteroids (the single most important intervention)
Corticosteroids accelerate fetal organ maturation and are the cornerstone of preterm labour management. Maximum benefit appears within 24 hours and effects last approximately 7 days.
Regimen:
- Betamethasone 12 mg IM every 24 hours x 2 doses, OR
- Dexamethasone 6 mg IM every 12 hours x 4 doses
Indications: 24-34 weeks with risk of preterm delivery within 7 days
- Consider also at 34-36+6 weeks (late preterm) if not previously given
- A single rescue course may be given if >2 weeks have passed since original course and gestation is still <34 weeks
Benefits established by evidence:
- Reduced RDS (hyaline membrane disease)
- Reduced intraventricular haemorrhage (IVH)
- Reduced necrotising enterocolitis (NEC)
- Reduced periventricular leukomalacia
- Reduced neonatal death
- Maximum benefit seen for births between 22-25 weeks
"Corticosteroids not only increase surfactant secretion in the fetal lung but also induce morphologic development of pulmonary epithelial cells and increase lung compliance... decreasing the incidence of NEC, IVH, periventricular leukomalacia, and death." - Mulholland & Greenfield's Surgery 7e
Principle 6: Choose Tocolytic Agent Thoughtfully
No single tocolytic is FDA-approved for this indication. Selection should be guided by gestational age, clinical circumstances, and maternal comorbidities.
First-line: Nifedipine (Calcium Channel Blocker) - WHO preferred
- Mechanism: blocks calcium entry into myometrial smooth muscle cells, reducing actin-myosin interaction
- Dosing: 10-20 mg oral loading dose, repeated every 3-6 hours until contractions settle, then 30-60 mg long-acting every 12-24 hours for 48 hours
- Advantages: oral, convenient, fewer maternal side effects than β-mimetics
- Cochrane evidence: effective in delaying delivery >48 hours; better neonatal outcomes and fewer maternal side effects vs β-mimetics
- Caution: avoid in hypotension, cardiac disease; do NOT combine with MgSO4 (risk of skeletal muscle blockade) or β-mimetics (cardiovascular interaction)
- Avoid doses >60 mg total in acute phase; do not chew short-acting tablets
Second-line options:
| Agent | Mechanism | Key Use / Notes |
|---|
| Indomethacin (COX inhibitor) | Reduces prostaglandin synthesis → decreases intracellular Ca²+ and myosin kinase activation | Use <32 weeks only. Loading 50-100 mg PO/PR, then 25-50 mg q6h x max 48 hours. Risk: ductal constriction (usually reversible), oligohydramnios |
| Magnesium sulphate | Ca²+ antagonism at myometrial level | IV: 4-6 g bolus over 20 min, then 1-3 g/h. Cochrane evidence shows it is ineffective as tocolytic; given in PTL mainly for neuroprotection <32 weeks |
| Terbutaline (β2-agonist) | Stimulates β2-adrenergic receptors → increases cAMP → reduces myosin kinase activity | 0.25 mg SC q20-60 min. High side-effect burden (tachycardia, arrhythmias, pulmonary oedema, hyperglycaemia, hypokalaemia). FDA warned against oral/SQ maintenance use. |
| Atosiban (oxytocin receptor antagonist) | Competitive inhibitor of oxytocin/vasopressin receptors | IV bolus + infusion. Minimal maternal side effects; widely used in Europe, not FDA-approved in USA |
Key prescribing rules:
- Do NOT combine nifedipine + MgSO4 (neuromuscular blockade)
- Do NOT combine nifedipine + IV β-mimetics (cardiovascular)
- Do not initiate tocolysis for unconfirmed labour
- Cochrane evidence favours nifedipine > β-mimetics > MgSO4 for tocolytic efficacy
Principle 7: Magnesium Sulphate for Fetal Neuroprotection (<32 weeks)
Separate from its role as a tocolytic (where evidence is weak), MgSO4 significantly reduces the risk of cerebral palsy in surviving preterm infants when given before delivery <32 weeks.
- Typical regimen: 4-6 g IV bolus + 1-2 g/h infusion until delivery
- Monitor for toxicity: respiratory depression (patellar reflexes lost at ~7-10 mEq/L, respiratory arrest at >12 mEq/L)
- Antidote: calcium gluconate 1 g IV
Principle 8: GBS Prophylaxis
Administer intrapartum antibiotic prophylaxis for Group B Streptococcus (GBS) if preterm delivery appears likely and GBS status is unknown or positive.
- First-line: Penicillin G 5 million units IV, then 2.5-3 million units q4h until delivery
- Penicillin allergy (low risk): Ampicillin 2 g IV, then 1 g q4h
- Penicillin allergy (high risk / anaphylaxis): Clindamycin or vancomycin (based on sensitivities)
Principle 9: Do NOT Use Maintenance Tocolysis
Once the initial 48-hour window has passed (corticosteroids given, transfer complete), maintenance tocolysis does not work and is not recommended.
- Cochrane reviews of oral β-mimetics, terbutaline pump, oxytocin antagonists, and calcium channel blockers all found no evidence of reduced preterm birth rate with maintenance therapy
- One study found infants exposed to maintenance calcium channel blockers had significantly longer NICU stays (mean 14 extra days)
- Outpatient uterine contraction monitoring and associated care did not improve delivery rates or birth weight
"Continued suppression of contractions after acute tocolysis (maintenance tocolysis) does not reduce the rate of preterm birth." - Creasy & Resnik's Maternal-Fetal Medicine
Principle 10: Plan for Delivery and Neonatal Care
If tocolysis fails or is not indicated, prepare for preterm delivery:
- Mode of delivery: Aim for slow, controlled vaginal delivery with minimal maternal expulsive effort; episiotomy and low forceps may be used for head protection
- Breech at <34 weeks: Caesarean section is generally preferred - soft cranium and cord prolapse risk
- Fetal indications for CS: Fetal distress, IUGR, failure to progress, malpresentation
- Analgesia: Epidural/spinal preferred - promotes pelvic relaxation and allows slow delivery
- Neonatal team: Alert NICU/paediatrics team for resuscitation; very preterm infants (<30 weeks) need immediate respiratory support
- Avoid: Prolonged cord compression; manage PROM with vigilance for ascending infection
Summary Framework
Suspected preterm labour
↓
Confirm diagnosis (cervical change + contractions)
↓
Exclude PROM, infection, contraindications to tocolysis
↓
Basic measures: O₂, hydration, left lateral position, treat UTI
↓
Give CORTICOSTEROIDS (betamethasone 12 mg IM x 2 doses over 24h)
↓
Give GBS prophylaxis if delivery likely
↓
Tocolysis (48-hour window only):
First-line → Nifedipine
<32 weeks → Add MgSO₄ for neuroprotection
<32 weeks → Consider indomethacin
↓
Arrange maternal transfer to tertiary centre if <34 weeks
↓
No maintenance tocolysis after 48 hours
↓
Plan delivery: mode, analgesia, NICU team
Sources: Creasy & Resnik's Maternal-Fetal Medicine; Roberts & Hedges' Clinical Procedures in Emergency Medicine; Goodman & Gilman's Pharmacological Basis of Therapeutics; Morgan & Mikhail's Clinical Anesthesiology 7e; Textbook of Family Medicine 9e; Mulholland & Greenfield's Surgery 7e